These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 16188922)

  • 1. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
    Dieterich W; Esslinger B; Trapp D; Hahn E; Huff T; Seilmeier W; Wieser H; Schuppan D
    Gut; 2006 Apr; 55(4):478-84. PubMed ID: 16188922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
    Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
    Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking peptides decrease tissue transglutaminase processing of gliadin in vitro.
    Hoffmann K; Alminger M; Andlid T; Chen T; Olsson O; Sandberg AS
    J Agric Food Chem; 2009 Nov; 57(21):10150-5. PubMed ID: 19813732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease.
    Skovbjerg H; Norén O; Anthonsen D; Moller J; Sjöström H
    Scand J Gastroenterol; 2002 Jul; 37(7):812-7. PubMed ID: 12190095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity.
    Dieterich W; Trapp D; Esslinger B; Leidenberger M; Piper J; Hahn E; Schuppan D
    Gut; 2003 Nov; 52(11):1562-6. PubMed ID: 14570723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
    Agardh D
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa.
    Ciccocioppo R; Di Sabatino A; Ara C; Biagi F; Perilli M; Amicosante G; Cifone MG; Corazza GR
    Clin Exp Immunol; 2003 Dec; 134(3):516-24. PubMed ID: 14632760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
    Dørum S; Qiao SW; Sollid LM; Fleckenstein B
    J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
    Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
    Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.
    Devery JM; La Brooy JT; Krillis S; Davidson G; Skerritt JH
    Clin Exp Immunol; 1989 Jun; 76(3):384-90. PubMed ID: 2752594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
    Skovbjerg H; Koch C; Anthonsen D; Sjöström H
    Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase-mediated cross-linking of a peptic fraction of omega-5 gliadin enhances IgE reactivity in wheat-dependent, exercise-induced anaphylaxis.
    Palosuo K; Varjonen E; Nurkkala J; Kalkkinen N; Harvima R; Reunala T; Alenius H
    J Allergy Clin Immunol; 2003 Jun; 111(6):1386-92. PubMed ID: 12789243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic validity of anti-tissue transglutaminase and anti-endomysium antibodies in children with celiac disease].
    Matusiewicz K; Iwańczak B; Matusiewicz M; Iwańczak F
    Pol Merkur Lekarski; 2006 Jan; 20(115):17-21. PubMed ID: 16617728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deamidated gliadin peptides as targets for celiac disease-specific antibodies.
    Mothes T
    Adv Clin Chem; 2007; 44():35-63. PubMed ID: 17682339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity.
    van de Wal Y; Kooy Y; van Veelen P; Peña S; Mearin L; Papadopoulos G; Koning F
    J Immunol; 1998 Aug; 161(4):1585-8. PubMed ID: 9712018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease.
    Prause C; Ritter M; Probst C; Daehnrich C; Schlumberger W; Komorowski L; Lieske R; Richter T; Hauer AC; Stern M; Uhlig HH; Laass MW; Zimmer KP; Mothes T
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):52-8. PubMed ID: 19465869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent aspects of antibody determination for the diagnosis of coeliac disease].
    Mothes T; Uhlig HH; Richter T
    Dtsch Med Wochenschr; 2009 Jul; 134(30):1525-8. PubMed ID: 19603369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity.
    Nicholas B; Smethurst P; Verderio E; Jones R; Griffin M
    Biochem J; 2003 Apr; 371(Pt 2):413-22. PubMed ID: 12533191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wheat gliadin fractions and other cereal antigens reactive with antibodies in the sera of coeliac patients.
    Kieffer M; Frazier PJ; Daniels NW; Coombs RR
    Clin Exp Immunol; 1982 Dec; 50(3):651-60. PubMed ID: 7166001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.